Abstract Details
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Michael D. Hill, MD (University of Calgary) | Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular. |
| John K. Fink, MD | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Thomas G. Brott, MD, FAAN (Mayo Clinic) | Dr. Brott has nothing to disclose. |